<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01050010</url>
  </required_header>
  <id_info>
    <org_study_id>09-CIR-01</org_study_id>
    <nct_id>NCT01050010</nct_id>
  </id_info>
  <brief_title>The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study</brief_title>
  <official_title>The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission.Preliminary Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The major aim of treatment for rheumatoid arthritis is remission. Nevertheless, structural
      radiographic progression is observed in 15 to 20% of patient getting remission. Numerous
      definitions of the remission proposed by literature remain imperfect.

      Recently ultrasonography and MRI seem to be helpful in diagnosis and follow-up of rheumatoid
      arthritis.

      Studies in patients with clinical remission are reporting 75 to 90% of persistent MRI and
      ultrasonography synovitis, 45% of cases with synovial activity.

      To our knowledge, in such case few studies showed correlation between persistent imaging
      synovitis and structural radiographic progression.

      On the other hand, no studies with extremity dedicated RMI in patients with remission are
      reported.

      In this preliminary study, the investigators propose to evaluate in patients with rheumatoid
      arthritis remission and persistent dedicated MRI synovitis the structural radiographic
      progression at one year.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dedicated extremity MRI (hand and wrist)/ X-Ray (hand, wrist and foot)</measure>
    <time_frame>at Month 0 (first visit) and Month 12 (last visit)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ultrasonography (hand, wrist and foot)</measure>
    <time_frame>at Month 0 (first vist) and Month 12 (last visit)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Dedicated extremity MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Structural deterioration radiographic assessed by dedicated extremity MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>dedicated extremity MRI</description>
    <arm_group_label>Dedicated extremity MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Earlier rheumatoid arthritis (&lt;1 year)

          -  Clinical remission (DAS 28 &lt;2,6 ou SDAI &lt;5) since 6 months before the inclusion

          -  Unchanged DMARds and /or biologic therapy since 6 months before the inclusion

          -  Unchanged corticosteroid (5 mg/day) since 3 months before the inclusion in patients
             treated with this therapy

          -  No contre-indication to the MRI

        Exclusion Criteria:

          -  Contra-indication to MRI

          -  Pregnant or breast-feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine ALBERT-SABONNADIERE, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nice University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine ALBERT-SABONNADIERE, PhD</last_name>
    <email>albert-sabonnadiere.c@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de NICE</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine ALBERT-SABONNADIERE, M.D.</last_name>
      <phone>0492035481</phone>
    </contact>
    <investigator>
      <last_name>Christine ALBERT-SABONNADIERE, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rheumatology Department, Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christine ALBERT-SABONNADIERE, PhD</last_name>
      <email>albert-sabonnadiere.c@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2010</study_first_submitted>
  <study_first_submitted_qc>January 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2010</study_first_posted>
  <last_update_submitted>December 8, 2011</last_update_submitted>
  <last_update_submitted_qc>December 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rheumatoid arthritis</keyword>
  <keyword>clinical remission</keyword>
  <keyword>synovitis</keyword>
  <keyword>dedicated extremity MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Synovitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

